No Data
No Data
Heart Heart Medical (688016.SH) 2023 equity distribution: 3 yuan per share, free 0.49 shares, shares registered on May 13
Heart Heart Healthcare (688016.SH) issued the 2023 equity distribution implementation notice. This time, profits will be distributed to Israel...
Cardiac Healthcare (688016.SH) announced first-quarter results, net profit of 184 million yuan, up 47.62% year-on-year
Heart Heart Healthcare (688016.SH) disclosed its report for the first quarter of 2024. The company achieved operating revenue during the reporting period...
Is Shanghai MicroPort Endovascular MedTech Co., Ltd. (SHSE:688016) Worth CN¥178 Based On Its Intrinsic Value?
Key Insights Shanghai MicroPort Endovascular MedTech's estimated fair value is CN¥146 based on 2 Stage Free Cash Flow to Equity Current share price of CN¥178 suggests Shanghai MicroPort Endovascular
Shanghai MicroPort Endovascular MedTech's (SHSE:688016) Earnings Are Weaker Than They Seem
Shanghai MicroPort Endovascular MedTech Co., Ltd. (SHSE:688016) just reported some strong earnings, and the market reacted accordingly with a healthy uplift in the share price. However, we think that
Analysts Have Made A Financial Statement On Shanghai MicroPort Endovascular MedTech Co., Ltd.'s (SHSE:688016) Annual Report
It's been a good week for Shanghai MicroPort Endovascular MedTech Co., Ltd. (SHSE:688016) shareholders, because the company has just released its latest yearly results, and the shares gained 3.7% to C
Minimally Invasive Healthcare (00853): Cardiac Medical Technology's net profit to the mother in 2023 was 492 million yuan, up 37.98% year-on-year
Minimally Invasive Healthcare (00853) released Affiliated Cardiac Medical Technology, which has been reviewed for 12 months ending December 31, 2023...
No Data